These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 38609391)

  • 1. Dual pH/redox-responsive hyperbranched polymeric nanocarriers with TME-trigger size shrinkage and charge reversible ability for amplified chemotherapy of breast cancer.
    Badparvar F; Marjani AP; Salehi R; Ramezani F
    Sci Rep; 2024 Apr; 14(1):8567. PubMed ID: 38609391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual pH/redox-responsive size-switchable polymeric nano-carrier system for tumor microenvironment DTX release.
    Badparvar F; Poursattar Marjani A; Salehi R; Ramezani F; Beyrampour Basmenj H; Talebi M
    J Biomater Sci Polym Ed; 2024 Oct; 35(14):2220-2249. PubMed ID: 38944817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced docetaxel therapeutic effect using dual targeted SRL-2 and TA1 aptamer conjugated micelles in inhibition Balb/c mice breast cancer model.
    Taghipour YD; Zarebkohan A; Salehi R; Talebi M; Rahbarghazi R; Khordadmehr M; Khavandkari S; Badparvar F; Torchilin VP
    Sci Rep; 2024 Oct; 14(1):24603. PubMed ID: 39427007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic chemo-photothermal cancer therapy of pH-responsive polymeric nanoparticles loaded IR825 and DTX with charge-reversal property.
    Wang X; Gu Y; Li Q; Xu Y; Shi Y; Wang Z; Xia M; Li J; Wang D
    Colloids Surf B Biointerfaces; 2022 Jan; 209(Pt 2):112164. PubMed ID: 34735859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. pH/redox responsive size-switchable intelligent nanovehicle for tumor microenvironment targeted DOX release.
    Badparvar F; Marjani AP; Salehi R; Ramezani F
    Sci Rep; 2023 Dec; 13(1):22475. PubMed ID: 38110480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor pH(e)-triggered charge-reversal and redox-responsive nanoparticles for docetaxel delivery in hepatocellular carcinoma treatment.
    Chen F; Zhang J; Wang L; Wang Y; Chen M
    Nanoscale; 2015 Oct; 7(38):15763-79. PubMed ID: 26355843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of polymeric nanoparticle intracellular targeting overcomes chemodrug resistance in human primary patient breast cancer cells.
    Abou-El-Naga AM; Mutawa G; El-Sherbiny IM; Mousa SA
    Int J Nanomedicine; 2018; 13():8153-8164. PubMed ID: 30555232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Facile synthesis of poly(disulfide)s through one-step oxidation polymerization for redox-responsive drug delivery.
    Zhang R; Nie T; Wang L; He D; Kang Y; Zhang C; Wu J
    Biomater Sci; 2023 Jun; 11(12):4254-4264. PubMed ID: 37144301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate-specific membrane antigen targeted, glutathione-sensitive nanoparticles loaded with docetaxel and enzalutamide for the delivery to prostate cancer.
    Chen Y; Xu Z; Lu T; Luo J; Xue H
    Drug Deliv; 2022 Dec; 29(1):2705-2712. PubMed ID: 35980107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Docetaxel-loaded pH/ROS dual-responsive nanoparticles with self-supplied ROS for inhibiting metastasis and enhancing immunotherapy of breast cancer.
    Wang Y; Wang Q; Wang X; Yao P; Dai Q; Qi X; Yang M; Zhang X; Huang R; Yang J; Wang Q; Xia P; Zhang D; Sun F
    J Nanobiotechnology; 2023 Aug; 21(1):286. PubMed ID: 37608285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-delivery of docetaxel and gemcitabine by anacardic acid modified self-assembled albumin nanoparticles for effective breast cancer management.
    Kushwah V; Katiyar SS; Dora CP; Kumar Agrawal A; Lamprou DA; Gupta RC; Jain S
    Acta Biomater; 2018 Jun; 73():424-436. PubMed ID: 29649635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. pH and redox dual-responsive copolymer micelles with surface charge reversal for co-delivery of all-
    Zhang Y; Peng L; Chu J; Zhang M; Sun L; Zhong B; Wu Q
    Int J Nanomedicine; 2018; 13():6499-6515. PubMed ID: 30410335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-delivery of Docetaxel and Disulfonate Tetraphenyl Chlorin in One Nanoparticle Produces Strong Synergism between Chemo- and Photodynamic Therapy in Drug-Sensitive and -Resistant Cancer Cells.
    Gaio E; Conte C; Esposito D; Miotto G; Quaglia F; Moret F; Reddi E
    Mol Pharm; 2018 Oct; 15(10):4599-4611. PubMed ID: 30148955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Facile fabrication of robust, hyaluronic acid-surfaced and disulfide-crosslinked PLGA nanoparticles for tumor-targeted and reduction-triggered release of docetaxel.
    Wang X; Cheng R; Zhong Z
    Acta Biomater; 2021 Apr; 125():280-289. PubMed ID: 33677162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Docetaxel (DTX)-loaded polydopamine-modified TPGS-PLA nanoparticles as a targeted drug delivery system for the treatment of liver cancer.
    Zhu D; Tao W; Zhang H; Liu G; Wang T; Zhang L; Zeng X; Mei L
    Acta Biomater; 2016 Jan; 30():144-154. PubMed ID: 26602819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclic RGD-Functionalized pH/ROS Dual-Responsive Nanoparticle for Targeted Breast Cancer Therapy.
    Yao P; Wang X; Wang Q; Dai Q; Peng Y; Yuan Q; Mou N; Lv S; Weng B; Wang Y; Sun F
    Pharmaceutics; 2023 Jun; 15(7):. PubMed ID: 37514014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. pH-triggered "PEG" sheddable and folic acid-targeted nanoparticles for docetaxel delivery in breast cancer treatment.
    Sui F; Fang Z; Li L; Wan X; Zhang Y; Cai X
    Int J Pharm; 2023 Sep; 644():123293. PubMed ID: 37541534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Redox-responsive nanoparticles based on Chondroitin Sulfate and Docetaxel prodrug for tumor targeted delivery of Docetaxel.
    Li Y; Chen X; Ji J; Li L; Zhai G
    Carbohydr Polym; 2021 Mar; 255():117393. PubMed ID: 33436222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Facile construction of bioreducible crosslinked polypeptide micelles for enhanced cancer combination therapy.
    Ruttala HB; Chitrapriya N; Kaliraj K; Ramasamy T; Shin WH; Jeong JH; Kim JR; Ku SK; Choi HG; Yong CS; Kim JO
    Acta Biomater; 2017 Nov; 63():135-149. PubMed ID: 28890258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactive oxygen species and glutathione dual responsive nanoparticles for enhanced prostate cancer therapy.
    Zhang L; Zhang S; Li M; Li Y; Xiong H; Jiang D; Li L; Huang H; Kang Y; Pang J
    Mater Sci Eng C Mater Biol Appl; 2021 Apr; 123():111956. PubMed ID: 33812584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.